Aurora Cannabis Expands Discount Program and Analyst Forecasts Diverge on Potential Upside or Downside
PorAinvest
sábado, 28 de junio de 2025, 5:44 pm ET1 min de lectura
ACB--
The changes to the compassionate pricing program are available alongside new medical cannabis products, including Aurora | Mediora Minis – Cannatonic CBD Flower, Sativa (10mg), Daily Special | Sativa J's - THC Pre-Rolls, Sativa (7 x 0.3g), and WMMC | Seasonal Stash Petro Biscuit – THC Flower, Indica (10mg) [1]. Aurora also offers resources to seniors, pediatric patients, veterans, first responders, and others seeking care through medical cannabis [1].
Aurora's stock price has seen a notable uptick following this strategic revision, with analysts forecasting a potential downside of 26.00% from the current trading price of $4.30 [2]. However, GuruFocus estimates suggest a contrasting potential upside of 37.09%, indicating different valuation perspectives [2]. The average one-year price target for Aurora Cannabis Inc. (ACB) stands at $3.18, with a consensus brokerage recommendation of 2.3, positioning it in the "Outperform" category [2].
Aurora's commitment to accessible medical cannabis is evident in its ongoing initiatives. The company continues to provide tailored resources for special demographic groups, reinforcing its role in breaking down barriers to high-quality cannabis. Patients can visit www.auroramedical.com for more information and to connect with the Aurora client care team [1].
References:
[1] https://www.cannabisbusinesstimes.com/industry-headlines/news/15749509/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program
[2] https://www.gurufocus.com/news/2948935/aurora-cannabis-acb-expands-discount-program-in-canada?mobile=true
[3] https://www.gurufocus.com/news/2947242/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program-acb-stock-news
Aurora Cannabis has expanded its discount program in Canada, increasing the income eligibility for compassionate pricing from $40,000 to $60,000, potentially boosting access to medical cannabis. Analysts forecast a potential downside for the stock price, while GuruFocus estimates suggest a contrasting potential upside. The company's stock price has risen following the strategic revision.
Aurora Cannabis Inc. (ACB) has recently expanded its compassionate pricing program in Canada, raising the annual income eligibility threshold from CA$40,000 to CA$60,000 [1]. This strategic move aims to enhance accessibility to medical cannabis products, providing a 30% discount to qualifying patients [2]. The program's expansion is expected to benefit over half of the adult population in Canada, making it the most inclusive medical cannabis pricing program in the country [3].The changes to the compassionate pricing program are available alongside new medical cannabis products, including Aurora | Mediora Minis – Cannatonic CBD Flower, Sativa (10mg), Daily Special | Sativa J's - THC Pre-Rolls, Sativa (7 x 0.3g), and WMMC | Seasonal Stash Petro Biscuit – THC Flower, Indica (10mg) [1]. Aurora also offers resources to seniors, pediatric patients, veterans, first responders, and others seeking care through medical cannabis [1].
Aurora's stock price has seen a notable uptick following this strategic revision, with analysts forecasting a potential downside of 26.00% from the current trading price of $4.30 [2]. However, GuruFocus estimates suggest a contrasting potential upside of 37.09%, indicating different valuation perspectives [2]. The average one-year price target for Aurora Cannabis Inc. (ACB) stands at $3.18, with a consensus brokerage recommendation of 2.3, positioning it in the "Outperform" category [2].
Aurora's commitment to accessible medical cannabis is evident in its ongoing initiatives. The company continues to provide tailored resources for special demographic groups, reinforcing its role in breaking down barriers to high-quality cannabis. Patients can visit www.auroramedical.com for more information and to connect with the Aurora client care team [1].
References:
[1] https://www.cannabisbusinesstimes.com/industry-headlines/news/15749509/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program
[2] https://www.gurufocus.com/news/2948935/aurora-cannabis-acb-expands-discount-program-in-canada?mobile=true
[3] https://www.gurufocus.com/news/2947242/aurora-expands-patient-access-to-medical-cannabis-in-canada-with-extended-compassionate-pricing-program-acb-stock-news

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios